TROPHY-U-01: Sacituzumab Govitecan for Platinum-ineligible Metastatic UC
Daniel P. Petrylak, MD, a Professor of Medicine and Urology at the Yale School of Medicine, overviews the TROPHY-U-01 study for platinum-ineligible patients with metastatic urothelial carcinoma who have progressed on checkpoint inhibitor therapy.